Northbrook, IL 60062 -- (SBWIRE) -- 10/09/2023 -- According to the new market research report "Clinical Decision Support Systems Market in terms of revenue was estimated to be worth $1.7 billion in 2023 and is poised to reach $2.5 billion by 2028, growing at a CAGR of 7.5% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. According to The Office of the National Coordinator for Health Information Technology (ONC), as of 2021, in the US approximately 96 percent of non-federal acute care hospitals and nearly 4 in 5 office-based physicians (78%) have implemented a certified Electronic Health Record (EHR) systems. This marks significant 10-year progress since 2011 when 28% of hospitals and 34% of physicians had adopted an EHR.

Browse in-depth TOC on "Clinical Decision Support Systems (CDSS) Market"
199 – Tables
38 – Figures
231 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18085342

The growth of this market is driven by the implementation of government regulations and initiatives to promote the adoption of HCIT solutions, increasing adoption of CDSS-enabled EHRs, growing collaborations and partnerships between stakeholders, rising incidence of medication errors, and the development of mHealth and big data tools. However, high investment requirements for the implementation of CDSS and inadequate interoperability coupled with rising data security concerns are factors expected to restrain the growth of this market during the forecast period.

Key Players:

Prominent players in this Clinical Decision Support Systems (CDSS) Market are Cerner Corporation (US), Change Healthcare (US), Epic Systems (US), MEDITECH (US), Philips Healthcare (Netherlands), Wolters Kluwer N.V. (Netherlands), Zynx Health (US), Elsevier B.V. (UK), IBM Watson Health (US), Allscripts Healthcare LLC (US), athenahealth (US), NextGen Healthcare (US), Siemens Healthineers (US), EBSCO Health (US), GE Healthcare (US), eClinicalWorks (US), RAMPMedical (Germany), The Medical Algorithms Company Limited (UK), Hera-MI (France), CureMD Healthcare (US), CareCloud, Inc (US), Visual DX (US), Stanson Health (US), First Databank, Inc (US), and Strata Decision Technology (US).

Impact of Covid-19 on The Clinical Decision Support Systems Market

Due to the COVID-19 outbreak, medical practices of all sizes are under immense pressure, and healthcare facilities worldwide have been overwhelmed by the large number of patients visiting them daily. The emergence of this pandemic drives the demand for correct diagnosis and treatment devices in several countries across the globe. In this regard, clinical decision support systems have proven to be very compatible, as they allow healthcare providers and physicians to monitor patients using digitally connected noninvasive devices. Moreover, the rapid increase in number of patients across the globe resulted in a shortage of hospital beds and healthcare workers. This has driven the demand for medical devices for vital signs monitoring. The COVID-19 pandemic also increased the need for social distancing among physicians and patients, which has driven the demand for telehealth solutions and virtual consultation. Various players in this market have introduced COVID-19-associated features into their existing EHRs, which are being made available to users free of cost.

Software segment is expected to grow at the highest rate during the forecast period

The CDSS market is segmented based on components: services, software, and hardware. In 2021, the services segment accounted for the largest share of this market. Growth in this segment can be attributed to the recurring nature of services such as training and development, installation, consulting, and maintenance.

The On-premise solutions segment is estimated to account for the largest share of the Clinical decision support systems market in 2022

Clinical decision support systems are delivered to end users through on-premise and cloud-based modes. The on-premise mode of delivery accounted for the largest share of the clinical decision support systems market in 2021. The cloud-based mode of delivery, on the other hand, is estimated to grow at the highest CAGR due to comparatively lower capital expenses and operational costs incurred in this model, alongside its scalability, flexibility, and affordability.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18085342

Conventional CDSS segment accounted for the largest share of the global Clinical decision support systems market

Based on application, the CDSS market is segmented into conventional CDSS and advanced CDSS. In 2021, the conventional CDSS segment accounted for the largest share of the market, primarily owing to the increasing adoption of CDSS by healthcare organizations to provide guidance & reminders to caregivers at the point-of-care.

Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems market

Based on product, the CDSS market is segmented into integrated CDSS and standalone CDSS. In 2021, the integrated CDSS segment accounted for the largest share of the market. The large share of this segment can be attributed to the growing deployment of integrated CDSS in healthcare settings.

The therapeutic CDSS segment is expected to grow with the highest CAGR during the forecast period

Based on type, the clinical decision support systems market is segmented into therapeutic CDSS and diagnostic CDSS. The therapeutic CDSS segment dominated this market in 2021. This segment is estimated to grow at a higher CAGR during the forecast period. This segments large share and high growth rate can be attributed therapeutic CDSS being preferred by clinicians over diagnostic CDSS as it can be better integrated into clinical workflows. It is also convenient to use, as it doesn't restrict the healthcare provider's autonomy.

Knowledge-based CDSS segment accounted for the largest share of the global Clinical decision support systems market

Based on the model, the CDSS market is segmented into knowledge-based CDSS and non-knowledge-based CDSS. In 2021, the knowledge-based CDSS segment accounted for the largest share of the market. This segment is also estimated to register the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the several beneficial functionalities of these systems, such as helping clinicians with knowledge-based reasoning to make clinical decisions in uncertainties. These systems can also be integrated into clinical workflows and are less prone to errors than non-knowledge-based systems.

Request 10% Customization: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=18085342

The Active CDSS segment is expected to grow with the highest CAGR during the forecast period

Based on the interactivity level, the CDSS market can be segmented into active CDSS and passive CDSS. The active CDSS segment accounted for the largest share of the market in 2021 and is projected to grow at the highest CAGR during the forecast period.

Inpatient settings accounted for the largest share of the global Clinical decision support systems market

Based on setting, the CDSS market is segmented into inpatient and ambulatory care settings. Inpatient settings accounted for the largest share of the CDSS market in 2021. Inpatient settings need to capture and analyze large volumes of patient data, which results in the increasing adoption of integrated healthcare IT modules.

North America to dominate the Clinical decision support systems market in 2022

North America accounted for the largest share of the global clinical decision support systems (CDSS) market in 2021. The large share of the North American market can be attributed to the significant investments in HCIT solutions, regulatory mandates favoring the implementation of CDSS, the presence of major market players in the region, and the rising number of medication errors in the US and Canada.

The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the factors such as the presence of a large senior population, improved government legislation, the high burden of chronic diseases, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the CDSS market in Asia.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com